Successful triple valve replacement was performed in a patient with EuroSCORE II 19.24% after recurrent infective endocarditis following COVID-19 infection.
Demonstrates the feasibility of successful triple valve replacement in a high-risk patient with recurrent infective endocarditis following COVID-19.
Absolute Event Rate: 0% vs 0%
The authors present redo mitral valve replacement, aortic valve and tricuspid valve replacement in a patient with recurrent infective endocarditis following COVID-19 infection. This patient with EuroSCORE II 19.24% underwent successful triple valve replacement.
Podchasov et al. (Thu,) reported a other. Successful triple valve replacement was performed in a patient with EuroSCORE II 19.24% after recurrent infective endocarditis following COVID-19 infection.